March 13, 2018
REV.1 Engineering catheter device development.

Convergence, Innovation and the Future of Interventional Cardiology

Having spent the past two days walking the exhibit hall at this year’s American College of Cardiology Conference, I got to thinking about convergence, innovation and the direction of new product development in this segment. There’s a precedent of success for new product development that emerges from converging existing technologies, accompanied by key design improvements, that are then applied in innovative ways. The smartphone is a great example. Touchscreens, cellular technology, operating systems, digital cameras […]
February 28, 2018
Innovation at REV.1 Engineering

A Culture of Innovation

In our last blog, we spoke about the source of innovation – human creativity. If human creativity is the seed of innovation, organizational culture is the soil in which it must germinate and grow. While this may sound a bit lyrical coming from an engineering and medical products development firm, it’s actually grounded in scientific research. Research exploring the relationship between employee engagement and financial performance driven by innovation and new product commercialization. For well […]
February 12, 2018

The Innovation Conundrum

A current theme is buzzing throughout the medical device development community. It has to do with innovation, and more importantly, how organizations create and drive innovation. In product pipelines, standards of care, patient engagement and patient experience. Unfortunately for the industry, most companies fail to fully understand and embrace the source of innovation. Lacking these insights, organizations struggle to spark, kindle and sustain a highly innovative development model. Traditional R&D has focused its attention on […]
January 30, 2018

The Role of Health Technology Assessments in High Performance Development & Innovation

Other than pharmaceutical and technology companies, no other industry invests a greater percentage of revenue into R&D than medical device (holding steady at an average of 6.7%). The returns on these investments in innovation are, however, under stress. According to a Deloitte study published in 2016, pharmaceutical company returns on R&D have fallen from 10.1% in 2010 to 3.7% in 2016. Similar concerns are arising in med device, and companies are exploring new methodologies to […]
Schedule a Conversation
Contact Us